BMY - NYSE - 3/15/2010 8:00 PM
| Current | Overall Rank | Sector Rank | Industry Rank |
|---|---|---|---|
| -4.12% | 2604 / 4575 | 358 / 509 | 14 / 18 |
| Healthcare | Drug Manufacturers - Major |
| Period | Revenue Growth |
|---|---|
| Jun/00 | 7.22% |
| Sep/00 | -9.46% |
| Dec/00 | 1.65% |
| Mar/01 | -10.86% |
| Jun/01 | -10.73% |
| Sep/01 | 3.94% |
| Dec/01 | -3.91% |
| Mar/02 | -12.95% |
| Jun/02 | -13.93% |
| Sep/02 | -12.06% |
| Dec/02 | -9.24% |
| Mar/03 | 15.41% |
| Jun/03 | 24.65% |
| Sep/03 | 27.95% |
| Dec/03 | 16.21% |
| Mar/04 | 9.98% |
| Jun/04 | 7.48% |
| Sep/04 | 1.69% |
| Dec/04 | -7.43% |
| Mar/05 | -12.53% |
| Jun/05 | -9.96% |
| Sep/05 | -12.16% |
| Dec/05 | -2.68% |
| Mar/06 | 3.18% |
| Jun/06 | -0.37% |
| Sep/06 | -12.86% |
| Dec/06 | -16.06% |
| Mar/07 | -4.28% |
| Jun/07 | 1.17% |
| Sep/07 | 21.57% |
| Dec/07 | 27.72% |
| Mar/08 | 15.75% |
| Jun/08 | 5.58% |
| Sep/08 | 4.04% |
| Dec/08 | -2.45% |
| Mar/09 | -3.20% |
| Jun/09 | 3.48% |
| Sep/09 | 4.43% |
| Dec/09 | -4.12% |
RT @HometownStocks: Perspectives on Strategic M&A in Pharma by Pfizer Inc. Capital IQ Monthly Market Observations 03/10. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
CapitalIQ about 20 hours ago.
Candlestick Doji Pattern: stock hitting new low - $BMY - http://www.dojispace.com/stock-picks/bristol-myers-stock-price-BMY.aspx
ningtrader about a day ago.
Perspectives on Strategic M&A in Pharma by Pfizer Inc. Capital IQ Monthly Market Observations 03/10. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
Pharma trend: looking at complementary or diversified businesses. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
Pharma trend: Huge growth in emerging markets like China. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
Pharma trend:Pfizer/Wyeth,Merck/Schering,Roche/Genentech. cost synergy. diversifying revenue. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY
HometownStocks about 3 days ago.
Pharma trend: Revenue declines. Return on R&D declines. Industry consolidation. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
Pharma trend: Generic’s are the winners when things go off the patent. keynote by Kristin Peck. $PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
Pharma trend: loss of exclusivity, $314B in products patent expire in next 5 yrs. keynote by Kristin Peck.$PFE,$MRK,$BMY,$LLY,$GSK,$JNJ,$NVS
HometownStocks about 3 days ago.
A Black-Box Warning for Plavix. Confusion May Follow (at The Wall Street Journal Online)
Mar 12 05:42 PM EST.
RT @mhuckman: While in the air,bloodthinner Plavix from Bristol&Sanofi $BMY $SNY got new boxed warning. FDA doesn't want us 2 call it 'black box' anymore.
blehr11 about 4 days ago.
RT @mhuckman: While in the air,bloodthinner Plavix from Bristol&Sanofi $BMY $SNY got new boxed warning. FDA doesn't want us 2 call it 'black box' anymore.
IJALM about 4 days ago.
While in the air,bloodthinner Plavix from Bristol&Sanofi $BMY $SNY got new boxed warning. FDA doesn't want us 2 call it 'black box' anymore.
mhuckman about 4 days ago.
Mar 12 01:08 PM EST.
Interesting BioSante GVAX data in leukemia targets minimal residual disease post imatinib therapy http://bit.ly/96tBLZ $BPAX $NVS $BMY
MaverickNY about 4 days ago.
$BMY (Bristol-Myers Squibb) $25.89 crossed its 1st Pivot Point Resistance #emppv #stocks http://empirasign.com/s/7y8
empirasign_eq about 5 days ago.
RT @mhuckman: Small co, small study fyi RT @MaverickNY: My take on the BioSante GVAX data in leukemia: http://bit.ly/96tBLZ $BPAX $NVS $BMY
Newbietrader1 about 5 days ago.
Small co, small study fyi RT @MaverickNY: My take on the BioSante GVAX data in leukemia: http://bit.ly/96tBLZ $BPAX $NVS $BMY
mhuckman about 5 days ago.
My take on the BioSante GVAX data in leukemia: http://bit.ly/96tBLZ $GPAX $NVS $BMY
MaverickNY about 5 days ago.
$BMY (Bristol-Myers Squibb) $25.62 crossed its 3rd Pivot Point Resistance #emppv #stocks http://empirasign.com/s/7e8
empirasign_eq about 6 days ago.
Biotechs Jump on Facet, Intermune Deal - Stocks To Watch Today - Barrons.com $ITMN $ABT $FACT $OSIP $JNJ $BMY $BSX $XBI http://bit.ly/aJDahM
barronsstocks about 6 days ago.
RT @MaverickNY: The Abbott-Facet Biotech deal: Let the dance begin http://bit.ly/bJF2eH $ABT $FACT $BMY $BIIB
WriterChik about 6 days ago.
Abbot Bids 66% Premium for Facet’s Oncology Drugs - Stocks To Watch Today - Barrons.com $ABT $FACT $JNJ $PFE $BSX $BMY http://bit.ly/cEfsR7
barronsstocks about 6 days ago.
RT @mhuckman: 1 more thing on Bristol $BMY CEO $1.5m pay cut last yr. Still made $18.2m, but said @ analyst mtg last wk he'll soon "b on fixed income."
mccannpj about 6 days ago.
1 more thing on Bristol $BMY CEO $1.5m pay cut last yr. Still made $18.2m, but said @ analyst mtg last wk he'll soon "b on fixed income."
mhuckman about 6 days ago.
RT @odomlewis: RT @mhuckman: How's this 4 a change? Bristol $BMY says CEO Cornelius took $1.5m pay cut last yr. Still made $18.2m[obscene]
MeredithGould about 6 days ago.
Looking forward to participating in SXSWi panel "Data Is Money" with @apatzer, @womanwportfolio, Jesper Anderson, Allison Brady #datamoney
about 3 days ago. | Follow Us
